These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33452316)

  • 1. Amikacin and bacteriophage treatment modulates outer membrane proteins composition in Proteus mirabilis biofilm.
    Maszewska A; Moryl M; Wu J; Liu B; Feng L; Rozalski A
    Sci Rep; 2021 Jan; 11(1):1522. PubMed ID: 33452316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of polyvalent bacteriophages to combat biofilm of Proteus mirabilis causing catheter-associated urinary tract infections.
    Maszewska A; Zygmunt M; Grzejdziak I; Różalski A
    J Appl Microbiol; 2018 Nov; 125(5):1253-1265. PubMed ID: 29924909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of multidrug-resistant Proteus mirabilis biofilms using bacteriophages.
    Gomaa S; Serry F; Abdellatif H; Abbas H
    Arch Virol; 2019 Sep; 164(9):2265-2275. PubMed ID: 31197549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and Characterization of a Lytic Bacteriophage (vB_PmiS-TH) and Its Application in Combination with Ampicillin against Planktonic and Biofilm Forms of Proteus mirabilis Isolated from Urinary Tract Infection.
    Yazdi M; Bouzari M; Ghaemi EA
    J Mol Microbiol Biotechnol; 2018; 28(1):37-46. PubMed ID: 29617701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Probiotics Bacillus subtilis KATMIRA1933 and Bacillus amyloliquefaciens B-1895 Co-Aggregate with Clinical Isolates of Proteus mirabilis and Prevent Biofilm Formation.
    Algburi A; Alazzawi SA; Al-Ezzy AIA; Weeks R; Chistyakov V; Chikindas ML
    Probiotics Antimicrob Proteins; 2020 Dec; 12(4):1471-1483. PubMed ID: 31989448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to ciprofloxacin by enhancement of antioxidant defenses in biofilm and planktonic Proteus mirabilis.
    Aiassa V; Barnes AI; Albesa I
    Biochem Biophys Res Commun; 2010 Feb; 393(1):84-8. PubMed ID: 20097163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lytic bacteriophage PM16 specific for Proteus mirabilis: a novel member of the genus Phikmvvirus.
    Morozova V; Kozlova Y; Shedko E; Kurilshikov A; Babkin I; Tupikin A; Yunusova A; Chernonosov A; Baykov I; Кondratov I; Kabilov M; Ryabchikova E; Vlassov V; Tikunova N
    Arch Virol; 2016 Sep; 161(9):2457-72. PubMed ID: 27350061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of Imipenem Resistance in a CpxA-H208P-Variant-Producing
    Lecuru M; Nicolas-Chanoine MH; Tanaka S; Montravers P; Armand-Lefevre L; Denamur E; Mammeri H
    Microb Drug Resist; 2021 Jun; 27(6):747-751. PubMed ID: 33232636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and Purification of Proteus mirabilis Bacteriophage.
    Maszewska A; Różalski A
    Methods Mol Biol; 2019; 2021():231-240. PubMed ID: 31309509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.
    Saavedra S; Vera D; Ramírez-Ronda CH
    Am J Med; 1986 Jun; 80(6B):65-70. PubMed ID: 3014877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of polyvalent bacteriophages specific to uropathogenic Proteus mirabilis strains based on the host range pattern and RFLP.
    Maszewska A; Wójcik E; Ciurzyńska A; Wojtasik A; Piątkowska I; Dastych J; Różalski A
    Acta Biochim Pol; 2016; 63(2):303-10. PubMed ID: 26730411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permeability to carbapenems of Proteus mirabilis mutants selected for resistance to imipenem or other beta-lactams.
    Villar HE; Danel F; Livermore DM
    J Antimicrob Chemother; 1997 Sep; 40(3):365-70. PubMed ID: 9338488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of Proteus mirabilis O3 (S1959), O9 and O18 strains in normal human serum (NHS) correlates with the diversity of their outer membrane proteins (OMPs).
    Futoma-Kołoch B; Bugla-Płoskońska G; Doroszkiewicz W; Kaca W
    Pol J Microbiol; 2006; 55(2):153-6. PubMed ID: 17419294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage P2-71 against multi-drug resistant
    Dong Z; Wu R; Liu L; Ai S; Yang J; Li Q; Fu K; Zhou Y; Fu H; Zhou Z; Liu H; Zhong Z; Qiu X; Peng G
    Front Cell Infect Microbiol; 2024; 14():1347173. PubMed ID: 38500503
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of three lytic bacteriophages for eradicating biofilms of multidrug-resistant Proteus mirabilis.
    Esmael A; Abo-Elmaaty SA; Khafaga EM; Abdelrahman S; Hassan MG
    Arch Virol; 2021 Dec; 166(12):3311-3322. PubMed ID: 34559314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and microbiologic consequences of amikacin use during a 42-month period.
    Berk SL; Alvarez S; Ortega G; Verghese A; Holtsclaw-Berk SA
    Arch Intern Med; 1986 Mar; 146(3):538-41. PubMed ID: 3954526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of polyphosphate kinase in virulence and stress tolerance of uropathogenic Proteus mirabilis.
    Peng L; Jiang Q; Pan JY; Deng C; Yu JY; Wu XM; Huang SH; Deng XY
    Med Microbiol Immunol; 2016 Apr; 205(2):97-109. PubMed ID: 26233310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin inhibits swarming motility and activates biofilm production of Proteus mirabilis possibly by interacting with central regulators, metabolic status or active pump proteins.
    Aygül A; Öztürk İ; Çilli FF; Ermertcan Ş
    Phytomedicine; 2019 Apr; 57():65-71. PubMed ID: 30668324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of motility and adherence of Proteus mirabilis to uroepithelial cells by subinhibitory concentrations of amikacin.
    Tawfik AF; Ramadan MA; Shibl AM
    Chemotherapy; 1997; 43(6):424-9. PubMed ID: 9395856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.
    Drasar FA; Farrell W; Maskell J; Williams JD
    Br Med J; 1976 Nov; 2(6047):1284-7. PubMed ID: 1000196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.